FFAR1/GPR40 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB100-1537
Key Product Details
Species Reactivity
Human
Applications
Validated:
Peptide ELISA, Western Blot
Cited:
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence CAARTQGGKSQK corresponding to C-Terminus according to NP_005294.1.
Epitope
C Terminus
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for FFAR1/GPR40 Antibody
![Western Blot: FFAR1/GPR40 Antibody [NB100-1537]](https://resources.bio-techne.com/images/products/FFAR1-GPR40-Antibody-Western-Blot-NB100-1537-img0002.jpg "Western Blot: FFAR1/GPR40 Antibody [NB100-1537]")
Western Blot: FFAR1/GPR40 Antibody [NB100-1537]
Western Blot: FFAR1/GPR40 Antibody [NB100-1537] - (0.01ug/ml) staining of Human Breast lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.Applications for FFAR1/GPR40 Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:16000
Western Blot
0.01 - 0.03 ug/ml
Application Notes
WB: Approx. 28 kDa band observed in human breast lysates (calculated MW of 31.5 kDa band according to NP_005294.1).
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: FFAR1/GPR40
Long Name
Free Fatty Acid Receptor 1
Alternate Names
FFA1, GPR40
Entrez Gene IDs
2864 (Human)
Gene Symbol
FFAR1
UniProt
Additional FFAR1/GPR40 Products
Product Documents for FFAR1/GPR40 Antibody
Product Specific Notices for FFAR1/GPR40 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...